info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +18317045538    uk UK: +441256636046    in IN: +918260836500
Home » Healthcare » Breast Imaging Market Size, Global Trends | Forecast 2030

Breast Imaging Market By Technology (Ionizing Breast Imaging, Non-ionizing Breast Imaging), End-User (Hospitals & Clinics, Diagnostic Imaging Centers, Breast Care Centers) By Geography, Segment revenue estimation, Forecast: 2021-2030

Published On: Jan-2022   |   Base Year: 2021   |   No Of Pages: 140   |   Historical Data: 2015 - 2019   |   Formats: PDF   |   Report ID: 89433315

Report DescriptionTable of Contents

Industry Statistics and Insights

The global breast imaging market will witness a robust CAGR of 8.73%, valued at $4.14 billion in 2021, expected to appreciate and reach $8.79 billion by 2030, confirms Strategic Market Research.

Breast Imaging Market Based on Share

Key Industry Drivers - Rising prevalence of breast cancer and technological advancements

The continuous increase in the number of breast cancers is one of the essential factors that is propelling the growth of the breast imaging market significantly. According to WHO, in 2020, there were 2.3 Mn women diagnosed with breast cancer, and 685 000 deaths occurred globally. By the end of the year 2020, there were 7.8 Mn women alive who had been diagnosed with breast cancer in the last 5 years, thus making it one of the world's most prevalent types of cancer. Also, according to Breast Cancer.org, about 43,300 women in the U.S. are expected to die in 2022 due to breast cancer. The mortality rates have been steady among women under 50 since 2007 but have continued to drop among women over 50 years of age. The overall rate of death from breast cancer decreased by 1% each year from 2013 to 2018. These decreases are presumed to result from advanced treatment and earlier detection through screening processes. As of January 2021, there were more than 3.8 Mn women with a history of breast cancer in the U.S, including women who are currently being treated and women who have already finished their treatment. 

 

The rise in the number of breast cancer cases worldwide has led to the increase in the usage of a variety of breast screenings processes (breast MRI, breast tomosynthesis, Molecular breast imaging, Positron emission mammography, Contrast-enhanced mammography, Electrical impedance imaging, Elastography, gynecomastia ultrasound, mastitis ultrasound, breast sonogram, gynecomastia radiology, galactocele radiology, fibroadenoma radiology, fibrocystic breast disease radiology, breast cancer radiology) which is also fuelling the overall market growth. According to the U.S. FDA (Food and Drug Administration), 40 Mn mammograms are performed yearly in the United States. Mammography is considered one of the best methods for screening women for breast cancers.

 

Furthermore, rapid technological advancements in breast screening, a rising number of conferences worldwide on spreading awareness regarding the benefits of early screening and diagnosis, the rise of government and private investments to meet the increasing demand for breast cancer screening, and the excellent cancer screening reimbursement policies are widely augmenting the market's growth globally.

 

Breast Imaging Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 4.14 billion

The revenue forecast in 2030

USD 8.79 billion

Growth rate

CAGR of 8.73 %

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

Based on Technology, Based on End-User,  and By region.

Based on Technology

Ionizing Breast Imaging (Mammography, Molecular Breast Imaging (MBI), Positron Emission Tomography-Computed Tomography (PET-CT), Cone-beam Computed Tomography (CBCT), Positron Emission Mammography (PEM)

Non-ionizing Breast Imaging(Breast Ultrasound, Automated whole-breast Ultrasound (AWBU), Breast MRI, Electric Impedance Tomography, Breast thermography, Optical Imaging).

Based on End-User

Hospitals & Clinics, Diagnostic Imaging Centers, Breast Care Centers.

By Region

North America, Europe, Asia-Pacific, and LAMEA

Country Scope

US, Mexico, Canada, Germany, UK, France, China, Japan, India etc.

Company Usability Profiles

Hologic Inc., Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation, Canon Inc., Koninklijke Philips N.V., Aurora Healthcare US Corp., Allengers, Dilon Technologies, Inc., Planmed Oy, Delphinus Medical Technologies Inc., CMR Naviscan Corporation, Micrima Limited, SuperSonic Imagine, Carestream Health.

Pricing and purchase options

Customized buying options are available to meet your exact research needs.

 

Restraints - Overdiagnosis and Overtreatment

Overdiagnosis and overtreatment of breast cancer through mammography and repeated use of breast cancer screening technologies leading to a higher cost are some factors restraining the overall market growth.

 

Opportunities - Rise of government funds for Breast Cancer Screening

Governments all across the globe are now focusing on increasing the expenditure for breast cancer screenings worldwide. Along with that, the continuously improving reimbursement policies of breast cancer screenings and treatments are expected to present ample growth opportunities for the market players.

Breast Imaging Market Based on Share

Market Analysis Of Different Segments Covered in the Report

Based on Technology

Ionizing Breast Imaging

  • Mammography

                         o Full-field Digital Mammography (FFDM)

                         o Analog Mammography

                         o 3D Breast Tomosynthesis

  • Molecular Breast Imaging (MBI)

  • Positron Emission Tomography-Computed Tomography (PET-CT)

  • Cone-beam Computed Tomography (CBCT)

  • Positron Emission Mammography (PEM)

 

Non-ionizing Breast Imaging

  • Breast Ultrasound

  • Automated whole-breast Ultrasound (AWBU)

  • Breast MRI

  • Electric Impedance Tomography

  • Breast thermography

  • Optical Imaging

 

Based on End-User

  • Hospitals & Clinics

  • Diagnostic Imaging Centers

  • Breast Care Centers

 

Regional Coverage Analysis

  • North America

  • United States

  • Mexico

  • Canada

  • Rest of North America

 

Europe

  • Switzerland

  • Russia

  • France

  • Germany

  • U.K

  • Finland

  • Turkey

  • Netherlands 

  • Belgium

  • Spain

  • Italy

  • Rest of Europe

 

Asia Pacific

  • China

  • India

  • Indonesia

  • South Korea

  • Thailand

  • Japan

  • Singapore

  • Malaysia

  • Philippines

  • Australia

  • New Zealand

  • Rest of APAC

 

LAMEA

  • Brazil

  • Saudi Arabia

  • Uruguay

  • Argentina

  • Rest of LAMEA

 

Based on Technology, the ‘Non-ionizing Breast Imaging’ segment dominated the market in 2020 with the highest CAGR during the estimated period. Various advantages offered by the non-ionizing breast imaging technologies, such as the detection of small breast lesions in women with dense breast tissues and the depth of anatomical details for diagnosis, are fuelling the overall market growth in this region.

 

Among the ‘Non-ionizing Breast Imaging’ segment, the ‘Breast Ultrasound’ segment dominated the market comprehensively, with a total share of 58.71% of the entire breast imaging market and a CAGR of 11.18%. Factors like the lower risk of radiation exposure, the huge number of benefits offered by breast ultrasound, such as the ability to detect the direction of blood flow through vessels, and the capability to distinguish between a cyst and a solid mass are boosting the overall growth of this segment.

 

Based on End-User, the ‘Hospitals & Clinics’ segment significantly dominated the market in 2020 with a steady CAGR value. The rise of government funds for breast cancer treatments and healthcare infrastructures, the higher rate of admissions of breast cancer patients in the hospitals, and the presence of highly-skilled surgeons are stimulating the entire growth of the market in this segment.

 

Based on Region, North America dominated the entire market comprehensively with a total share of 39.47% of the entire market in 2020, owing to the continuous rising cases of breast cancers. According to National Breast Cancer Foundation, in 2020, an estimated 276,480 new cases of invasive breast cancer were detected in women in the United States. There were 48,530 new cases of non-invasive breast cancers.

 

The Asia-Pacific region held the fastest growth rate with the highest CAGR value throughout the estimated period. The continuous rising prevalence of breast cancers, the rise of healthcare expenditures, the rise of awareness programs for detecting breast cancers early, and the massive government spending on breast cancer research studies in several APAC countries are the major factors that are fuelling the growth of the breast imaging market in the Asia Pacific. According to GLOBOCAN 2018, 911,014 new breast cancer cases were diagnosed in Asia, and the number is expected to rise by 229,650 by 2030.

Breast Imaging Market Based on Region

Breast Imaging Market Competitive Landscape Analysis

A thorough competitive landscape analysis provides the most appropriate information about the crucial competitors in the breast imaging market environment. The comparison is performed based on various market initiatives, investment in R&D, company overview, total revenue generation, market potential, company strengths and weaknesses, company financials, global presence, production capacity, production sites, and facilities.

 

Recent Developments

  • On 6th December 2021, GE Healthcare announced that they are leveraging their USP of 3D Mammography and artificial intelligence to enhance breast cancer screening. The annual mammograms for early detection of breast cancer have made a huge difference in the lives of millions of women worldwide. Patient outcomes and accuracy will improve significantly with the incorporation of AI (artificial intelligence) and advanced technological imaging.

  • On 17th December 2020, Hologic added 3D Breast Ultrasound Imaging to the SuperSonic MACH 40 System. The system has a volumetric transducer that allows the users to easily acquire the 3D images with no resolution loss, regardless of where the lesion is situated within the breast.

  • On 3rd March 2020, Siemens Healthineers introduced new solutions for mammography workflow optimization and breast image reading. The new Teamplay Mammo Dashboard accurately tracks and analyses the breast imaging workflows and identifies bottlenecks.

Frequently Asked Question About This Report

b: Based on End-User, the Hospitals & Clinics segment dominated the market in 2020 significantly with a steady CAGR value.

b: The global breast imaging market size was $ 4.14 Bn in 2021 and is predicted to reach $ 8.79 Bn by 2030, with a CAGR of 8.73 %.

b: 8.73 % from 2021 to 2030 to reach USD 8.79 Billion by 2030.

b: Based on Technology, the Non-ionizing Breast Imaging segment dominated the market in 2020 with the highest CAGR during the estimated period.

b: Based on Region, North America dominated the entire market comprehensively with a total share of 39.47% of the entire market in 2020 owing to the continuous rising cases of breast cancers.

b: The most vital players of the market are Hologic Inc, Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation, Canon Inc, Koninklijke Philips N.V, Aurora Healthcare US Corp, Allengers Dilon Technologies, Inc, Planmed Oy, Delphinus Medical Technologies Inc, CMR Naviscan Corporation, Micrima Limited, SuperSonic Imagine, and Carestream Health.

Sources

https://www.who.int/news-room/fact-sheets/detail/breast-cancer

https://www.breastcancer.org/facts-statistics

https://www.nationalbreastcancer.org/wp-content/uploads/2020-Breast-Cancer-Stats.pdf

https://pubmed.ncbi.nlm.nih.gov/30207593/